发明名称 METHOD OF USING POTASSIUM CHANNEL INHIBITING COMPOUNDS
摘要 The present invention relates to the use of an effective amount of at least one potassium KvI.3 channel inhibitor or of an effective amount of at least one compound having in addition to its potassium KvI.3 channel inhibiting properties also CBx modulating properties and/or potassium K(atp) channel opening properties for the manufacture of a medicament for the prophylaxis, treatment, delayed progression, delayed onset and/or inhibition of various medical conditions in subjects in need thereof . The diseases are obesity, diabetes mellitus, metabolic syndrome, syndrome X, insulinoma, familial hyperinsulemic hypoglycemia, male pattern baldness, detrusor hyperreactivity, asthma, glucose metabolism - in particular, insulin resistance, hyperglycaemea and/or glucose intolerance - neuroprotection, epilepsy, analgesia, cardioprotection, angina, cardioplegia, arrhythmia, coronary spasm, peripheral vascular disease, cerebral vasospasm, appetite regulation, neurodegeneration, pain - including neuropathic pain and chronic pain - and impotence. The compounds are a.o. 4, 5-dihydropyrazole derivatives, imidazole derivatives, diazoxide, NN414, R(+) -WIN55212-2, HU-308, Rimonaband, SR-147778.
申请公布号 WO2007020286(A3) 申请公布日期 2007.05.10
申请号 WO2006EP65418 申请日期 2006.08.17
申请人 SOLVAY PHARMACEUTICALS GMBH;ANTEL, JOCHEN;GREGORY, PETER-COLIN;FIRNGES, MICHAEL;REICHE, DANIA 发明人 ANTEL, JOCHEN;GREGORY, PETER-COLIN;FIRNGES, MICHAEL;REICHE, DANIA
分类号 A61K31/549;A61K31/085;A61K31/415;A61K31/4155;A61K31/4439;A61K31/5383;A61P3/00;A61P3/04;A61P3/10;A61P9/00;A61P11/06;A61P13/10;A61P17/14;A61P25/00;A61P25/08 主分类号 A61K31/549
代理机构 代理人
主权项
地址